|
WUMC-Cancer and Leukemia Group B
|
5U10CA077440-10
|
$334,381
|
$3,344
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Virginia Mason Community Clinical Oncology Program
|
3U10CA035192-24S1
|
$80,000
|
$2,400
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-24
|
$391,000
|
$11,730
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
VCU Minority-Based CCOP
|
3U10CA052784-17S1
|
$100,000
|
$2,000
|
ROBERTS, JOHN
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Minority-Based CCOP
|
5U10CA052784-17
|
$527,332
|
$10,547
|
ROBERTS, JOHN
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Variations of care in older men with prostate cancer
|
5R03CA121338-02
|
$76,365
|
$19,091
|
JAYADEVAPPA, RAVISHANKAR
|
UNIVERSITY OF PENNSYLVANIA
|
|
Vanderbilt Phase I Translational Research Program
|
5U01CA099177-05
|
$100,037
|
$10,004
|
ROTHENBERG, MACE
|
VANDERBILT UNIVERSITY
|
|
Validation of Prognostic and Diagnostic molecular tests in Mesothelioma
|
5R01CA120528-02
|
$301,617
|
$75,404
|
BUENO, RAPHAEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
UT M.D. Anderson Cancer Center
|
2U10CA045809-19
|
$1,362,206
|
$13,622
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Use of Adjuvants to Improve Skin Genetic Immunizations
|
5R01CA100893-04
|
$256,389
|
$128,195
|
LARREGINA, ADRIANA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
2U10CA035119-23
|
$1,740,827
|
$52,225
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
UPMC McKeesport/ROCOG Radiation Oncology Minorities Out*
|
3U56CA105486-05S1
|
$110,772
|
$11,077
|
HERON, DWIGHT
|
UPMC MC KEESPORT
|
|
UPMC McKeesport/ROCOG Radiation Oncology Minorities Out*
|
5U56CA105486-05
|
$794,122
|
$79,412
|
HERON, DWIGHT
|
UPMC MC KEESPORT
|
|
University of Rochester Cancer Center CCOP Research Base
|
3U10CA037420-23S1
|
$146,724
|
$1,467
|
Morrow, Gary
|
UNIVERSITY OF ROCHESTER
|
|
University of Rochester Cancer Center CCOP Research Base
|
5U10CA037420-23
|
$1,131,018
|
$11,310
|
Morrow, Gary
|
UNIVERSITY OF ROCHESTER
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-20S2
|
$59,280
|
$2,964
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-20S3
|
$114,000
|
$5,700
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-20
|
$5,929,129
|
$296,456
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center CCOP*
|
3U10CA074648-06S1
|
$14,723
|
$736
|
Brenner, Dean
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Iowa CALGB Institutional Grant
|
5U10CA047642-20
|
$119,291
|
$1,193
|
VAENA, DANIEL
|
UNIVERSITY OF IOWA
|
|
University of Colorado Southwest Oncology Group
|
2U10CA042777-20
|
$82,102
|
$821
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER/HSC AURORA
|
|
University of Colorado Southwest Oncology Group
|
3U10CA042777-20S1
|
$356,613
|
$3,566
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER/HSC AURORA
|
|
Univ.of Calif., Irvine Cancer Center Support Grant
|
3P30CA062203-13S1
|
$68,952
|
$690
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
Univ.of Calif., Irvine Cancer Center Support Grant
|
3P30CA062203-13S2
|
$2,553,879
|
$25,539
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
Univ.of Calif., Irvine Cancer Center Support Grant
|
3P30CA062203-13S3
|
$59,791
|
$598
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
U10 Ful Member Application Affiliated with SWOG
|
5U10CA105409-04
|
$229,230
|
$2,292
|
LIPPMAN, SCOTT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Type II TGF Beta Receptor and RCC Progression
|
5R21CA113855-02
|
$111,432
|
$111,432
|
PARKER, ALEXANDER
|
MAYO CLINIC COLL OF MED, JACKSONVILLE
|
|
Tumor-induced immune suppression.
|
5R01CA115880-02
|
$253,359
|
$12,668
|
OSTRAND-ROSENBERG, SUZANNE
|
UNIVERSITY OF MARYLAND BALT CO CAMPUS
|
|
Tumor metastasis: Biobehavioral mechanisms
|
5R01CA110793-04
|
$329,855
|
$32,986
|
SOOD, ANIL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Translational Applications of mda-7/IL-24 in Cancer
|
5P01CA104177-03
|
$1,235,688
|
$308,922
|
FISHER, PAUL
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Transfer of the CD40 ligand gene to esophageal carcinoma
|
5R01CA101982-05
|
$357,594
|
$107,278
|
KORST, ROBERT
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
|
Total Lagrangian Explicit Dynamics Finite Element Method for Brain Registration
|
7R03CA126466-02
|
$87,774
|
$87,774
|
WARFIELD, SIMON
|
CHILDREN'S HOSPITAL BOSTON
|
|
Tomato-Soy Juice for Prostate Cancer
|
5R01CA112632-03
|
$279,963
|
$69,991
|
CLINTON, STEVEN
|
OHIO STATE UNIVERSITY
|
|
TOLEDO COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035415-24
|
$791,551
|
$31,662
|
SCHAEFER, PAUL
|
TOLEDO COMMUNITY HOSPITAL ONCOLOGY PROG
|
|
Timing of Rectal Cancer Response to Chemoradiation
|
5R01CA090559-05
|
$647,788
|
$323,894
|
GARCIA-AGUILAR, JULIO
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Therapeutics Studies of Primary CNS Malignancies
|
5U01CA062407-13
|
$161,227
|
$33,858
|
WEN, PATRICK
|
DANA-FARBER CANCER INSTITUTE
|
|
The Role of NC2 in Gene Repression by Tumor Hypoxia
|
5R01CA100132-04
|
$238,952
|
$59,738
|
DENKO, NICHOLAS
|
STANFORD UNIVERSITY
|
|
The role of JNK in Mammary tumor development
|
5R01CA100238-05
|
$278,349
|
$27,835
|
VAN DEN BERG, CARLA
|
UNIVERSITY OF TEXAS AUSTIN
|
|
The Pediatric Brain Tumor Consortium (PBTC)
|
5U01CA081457-09
|
$2,498,325
|
$649,565
|
BOYETT, JAMES
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
The Ohio State University Comprehensive Cancer Center-Supplement
|
3P30CA016058-32S1
|
$232,765
|
$6,983
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
The Ohio State University Comprehensive Cancer Center
|
3P30CA016058-32S2
|
$84,897
|
$2,547
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
The Ohio State University Comprehensive Cancer Center
|
5P30CA016058-32
|
$3,716,537
|
$111,496
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
The Gulf Coast MBCCOP
|
1U10CA128536-01
|
$400,000
|
$8,000
|
SCHWARZENBERGER, PAUL
|
SACRED HEART HEALTH SYSTEMS, INC.
|
|
Targeting the Tumor Vasculature to Treat Cancer
|
Z01 SC 010368
|
$689,963
|
$275,985
|
Libutti, Steven
|
CCR (NCI)
|
|
Targeted prostate biopsy using mathematical optimization
|
5R01CA104976-04
|
$399,975
|
$99,994
|
DAVATZIKOS, CHRISTOS
|
UNIVERSITY OF PENNSYLVANIA
|
|
Targeted antigen receptor treatment of cancer
|
5P01CA033049-24
|
$2,150,453
|
$215,045
|
HOUGHTON, ALAN
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Syracuse Hematology-Oncology CCOP
|
5U10CA045389-21
|
$536,473
|
$16,094
|
KIRSHNER, JEFFREY
|
HEMATOLOGY-ONCOLOGY ASSOCIATES/CTL NY
|
|
SWOG Institutional Grant
|
2U10CA073590-11
|
$1
|
$0
|
SONDAK, VERNON
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Survivor QOL/Spouse Satisfaction after Prostate Therapy
|
3R01CA095662-05S1
|
$222,647
|
$222,647
|
SANDA, MARTIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Surgical navigation system for in-bore MRI-guided breast interventions
|
5R44CA124238-07
|
$672,999
|
$672,999
|
Nevo, Erez
|
ROBIN MEDICAL, INC.
|
Total relevant funding to Surgery for this search: $63,184,035
|